Contact
Please use this form to send email to PR contact of this press release:
FTC Submits Proposed Amicus Brief Concerning "No-Authorized-Generic" Commitments in Drug Companies’ Patent Settlements
TO:
Please use this form to send email to PR contact of this press release:
FTC Submits Proposed Amicus Brief Concerning "No-Authorized-Generic" Commitments in Drug Companies’ Patent Settlements
TO: